Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

IDEA receives milestone for progression of targeted pain therapeutic

July 8, 2004

Elan submits Prialt NDA amendment

July 8, 2004

Comparison of sleep induction with melatonin, zaleplon, zopiclone and temazepam

July 8, 2004

Aventis Pharma scientists design new protein kinase inhibitors

July 7, 2004

Nymox pursues new approaches to combating Alzheimer's disease

July 7, 2004

Approvable letter for Agilect in Parkinson's disease

July 7, 2004

Canadian approval for initiation of phase II study of I.E.T. for MS

July 7, 2004

LY-156735 found effective and safe in primary insomnia

July 7, 2004

Novel potent and selective T-type calcium channel blockers

July 6, 2004

Modafinil beneficial in patients with schizophrenia

July 6, 2004

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026